Okairos okairos.it


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Okairos is a clinical-stage biopharmaceutical company, developing genetic vaccines for major infectious diseases - including malaria, hepatitis C, HIV, respiratory syncytial virus and cancer - using a novel proprietary technology. The company is also pursuing therapeutic vaccines to treat cancer.

Okairos is a clinical-stage biopharmaceutical company, developing genetic vaccines for major infectious diseases - including malaria, hepatitis C, HIV, respiratory syncytial virus and cancer - using a novel proprietary technology. The company is als...Show all

Company (Acquired)

Phone: +39 06 97246470

Fax:

Viale Città D'Europa 679

Rome, 00144
Italy

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Okairos $20.7M May 29, 2013
See all 18 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Okairos Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors

Competitors

Company Status Description Investors

Glaukos

Laguna Hills, California, United States
IPO / Went publicGlaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world's leading causes of blindness. We have pioneered Micro-Invasive Glaucoma Surgery, or MIGS, in order to revolutionize the traditional glaucoma treatment and management paradigm.Login to see details
See all 18 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotides Jul 05, 2013 Application